Yale Catriona
Insider CIK 1779308 · AKRO Chief Development Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| AKRO Akero Therapeutics, Inc. | D To issuer deriv | 2025-12-09 | 2025-12-09 | 3,421 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | D To issuer deriv | 2025-12-09 | 2025-12-09 | 5,032 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | D To issuer deriv | 2025-12-09 | 2025-12-09 | 2,328 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | D To issuer deriv | 2025-12-09 | 2025-12-09 | 70,279 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | D To issuer deriv | 2025-12-09 | 2025-12-09 | 131,205 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | D To issuer deriv | 2025-12-09 | 2025-12-09 | 84,051 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | D To issuer deriv | 2025-12-09 | 2025-12-09 | 33,421 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | D To issuer deriv | 2025-12-09 | 2025-12-09 | 52,785 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | D To issuer deriv | 2025-12-09 | 2025-12-09 | 74,053 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | D To issuer | 2025-12-09 | 2025-12-09 | 47,573 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | D To issuer | 2025-12-09 | 2025-12-09 | 27,227 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2025-11-04 | 2025-11-06 | 3,527 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2025-11-04 | 2025-11-06 | 4,739 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2025-11-04 | 2025-11-06 | 4,739 | $21.10 | $100.0K | 74,800 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2025-11-04 | 2025-11-06 | 3,527 | $28.35 | $100.0K | 70,061 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-09-11 | 2025-09-12 | 659 | $43.02 | $28.4K | 90,829 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2025-07-16 | 2025-07-18 | 10,000 | — | $0 | 131,205 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-07-16 | 2025-07-18 | 1,342 | $53.47 | $71.8K | 91,488 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-07-16 | 2025-07-18 | 8,658 | $52.87 | $457.7K | 92,830 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2025-07-16 | 2025-07-18 | 10,000 | $19.87 | $198.7K | 101,488 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award | 2025-06-30 | 2025-07-02 | 890 | $23.87 | $21.2K | 91,488 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-06-18 | 2025-06-20 | 1,633 | $54.84 | $89.6K | 90,598 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2025-06-16 | 2025-06-20 | 10,000 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-06-16 | 2025-06-20 | 895 | $55.52 | $49.7K | 92,231 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-06-16 | 2025-06-20 | 6,210 | $53.78 | $334.0K | 96,021 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2025-06-16 | 2025-06-20 | 10,000 | $21.10 | $211.0K | 102,231 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-06-16 | 2025-06-20 | 2,895 | $54.80 | $158.6K | 93,126 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-06-10 | 2025-06-12 | 2,803 | $54.00 | $151.4K | 92,231 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2025-05-15 | 2025-05-19 | 10,000 | — | $0 | 10,000 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-05-15 | 2025-05-19 | 4,384 | $39.91 | $175.0K | 95,034 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-05-15 | 2025-05-19 | 2,779 | $39.46 | $109.7K | 99,418 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-05-15 | 2025-05-19 | 2,837 | $38.20 | $108.4K | 102,197 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2025-05-15 | 2025-05-19 | 10,000 | $21.10 | $211.0K | 105,034 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2025-04-15 | 2025-04-16 | 9,073 | — | $0 | 20,000 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-04-15 | 2025-04-16 | 7,873 | $37.80 | $297.6K | 96,234 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-04-15 | 2025-04-16 | 1,200 | $38.62 | $46.3K | 95,034 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2025-04-15 | 2025-04-16 | 9,073 | $21.10 | $191.4K | 104,107 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2025-03-17 | 2025-03-18 | 10,000 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2025-03-17 | 2025-03-18 | 10,000 | $21.10 | $211.0K | 105,034 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-03-17 | 2025-03-18 | 8,201 | $44.70 | $366.6K | 96,833 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-03-17 | 2025-03-18 | 1,799 | $45.05 | $81.0K | 95,034 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-03-12 | 2025-03-14 | 614 | $44.88 | $27.6K | 95,034 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2025-02-18 | 2025-02-21 | 10,000 | — | $0 | 10,000 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-02-18 | 2025-02-21 | 9,100 | $49.79 | $453.1K | 96,548 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-02-18 | 2025-02-21 | 900 | $50.63 | $45.6K | 95,648 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2025-02-18 | 2025-02-21 | 10,000 | $21.10 | $211.0K | 105,648 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2025-01-27 | 2025-01-31 | 9,074 | — | $0 | 20,000 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2025-01-27 | 2025-01-31 | 20,000 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2025-01-27 | 2025-01-31 | 20,000 | — | $0 | 33,421 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2025-01-27 | 2025-01-31 | 16,849 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2025-01-27 | 2025-01-31 | 20,928 | — | $0 | 52,785 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2025-01-27 | 2025-01-31 | 641 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2025-01-27 | 2025-01-31 | 15,172 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-01-27 | 2025-01-31 | 14,467 | $55.95 | $809.4K | 104,348 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2025-01-27 | 2025-01-31 | 49,074 | $21.10 | $1.04M | 144,722 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-01-27 | 2025-01-31 | 25,907 | $55.15 | $1.43M | 118,815 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-01-27 | 2025-01-31 | 8,700 | $57.01 | $496.0K | 95,648 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-01-27 | 2025-01-31 | 27,340 | $57.02 | $1.56M | 95,648 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2025-01-27 | 2025-01-31 | 16,849 | $0.62 | $10.4K | 112,497 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2025-01-27 | 2025-01-31 | 15,172 | $6.36 | $96.5K | 127,669 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2025-01-27 | 2025-01-31 | 21,569 | $21.09 | $454.9K | 149,238 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-01-27 | 2025-01-31 | 17,000 | $55.16 | $937.7K | 132,238 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-01-27 | 2025-01-31 | 9,250 | $55.95 | $517.5K | 122,988 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2024-12-16 | 2024-12-18 | 9,074 | — | $0 | 20,000 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award deriv | 2024-12-16 | 2024-12-18 | 73,700 | — | $0 | 73,700 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award | 2024-12-16 | 2024-12-18 | 24,300 | — | $0 | 95,648 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2024-12-16 | 2024-12-18 | 9,074 | $21.10 | $191.5K | 104,722 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2024-12-16 | 2024-12-18 | 9,074 | $29.11 | $264.1K | 95,648 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2024-12-10 | 2024-12-12 | 2,810 | $30.79 | $86.5K | 71,348 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2024-11-15 | 2024-11-19 | 9,061 | — | $0 | 53,421 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2024-11-15 | 2024-11-19 | 9,061 | $21.10 | $191.2K | 83,219 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2024-11-15 | 2024-11-19 | 300 | $28.82 | $8.6K | 74,158 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2024-11-15 | 2024-11-19 | 8,761 | $27.69 | $242.6K | 74,458 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2024-11-06 | 2024-11-08 | 8,890 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2024-11-06 | 2024-11-08 | 1,110 | — | $0 | 16,849 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2024-11-06 | 2024-11-08 | 10,000 | $35.19 | $351.9K | 74,158 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2024-11-06 | 2024-11-08 | 10,000 | $0.62 | $6.2K | 84,158 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2024-11-01 | 2024-11-01 | 15,485 | — | $0 | 41,781 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2024-11-01 | 2024-11-01 | 15,485 | $32.62 | $505.1K | 74,158 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2024-11-01 | 2024-11-01 | 15,485 | $21.10 | $326.7K | 89,643 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2024-10-30 | 2024-11-01 | 4,515 | — | $0 | 57,266 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2024-10-30 | 2024-11-01 | 4,515 | $32.53 | $146.9K | 74,158 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2024-10-30 | 2024-11-01 | 4,515 | $21.10 | $95.3K | 78,673 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2024-10-15 | 2024-10-16 | 4,825 | — | $0 | 13,890 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2024-10-15 | 2024-10-16 | 10,000 | — | $0 | 17,959 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2024-10-15 | 2024-10-16 | 300 | $30.93 | $9.3K | 75,294 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2024-10-15 | 2024-10-16 | 14,525 | $30.50 | $443.0K | 75,594 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2024-10-15 | 2024-10-16 | 14,825 | $0.62 | $9.2K | 90,119 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2024-10-14 | 2024-10-16 | 5,000 | — | $0 | 8,890 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2024-10-14 | 2024-10-16 | 6,136 | $30.03 | $184.3K | 74,158 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2024-10-14 | 2024-10-16 | 5,000 | $0.62 | $3.1K | 80,294 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2024-09-20 | 2024-09-23 | 5,500 | — | $0 | 27,959 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2024-09-20 | 2024-09-23 | 5,500 | $27.65 | $152.1K | 75,294 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2024-09-20 | 2024-09-23 | 5,500 | $0.62 | $3.4K | 80,794 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2024-09-18 | 2024-09-18 | 3,871 | — | $0 | 33,459 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2024-09-18 | 2024-09-18 | 3,871 | $27.56 | $106.7K | 75,294 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2024-09-18 | 2024-09-18 | 3,871 | $0.62 | $2.4K | 79,165 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2024-09-17 | 2024-09-18 | 2,037 | — | $0 | 37,330 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2024-09-17 | 2024-09-18 | 2,037 | $27.55 | $56.1K | 75,294 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2024-09-17 | 2024-09-18 | 2,037 | $0.62 | $1.3K | 77,331 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2024-09-16 | 2024-09-18 | 2,485 | — | $0 | 39,367 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2024-09-16 | 2024-09-18 | 2,485 | $27.52 | $68.4K | 75,294 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2024-09-16 | 2024-09-18 | 2,485 | $0.62 | $1.5K | 77,779 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2024-09-10 | 2024-09-13 | 637 | $26.18 | $16.7K | 75,294 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2024-09-03 | 2024-09-05 | 949 | — | $0 | 18,715 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2024-09-03 | 2024-09-05 | 949 | $27.61 | $26.2K | 75,931 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2024-09-03 | 2024-09-05 | 949 | $0.62 | $588 | 76,880 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2024-08-26 | 2024-08-28 | 5,200 | — | $0 | 19,664 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2024-08-26 | 2024-08-28 | 5,200 | $0.62 | $3.2K | 81,131 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2024-08-26 | 2024-08-28 | 5,200 | $27.51 | $143.1K | 75,931 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2024-08-23 | 2024-08-28 | 8,851 | — | $0 | 24,864 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2024-08-23 | 2024-08-28 | 8,851 | $27.53 | $243.7K | 75,931 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2024-08-23 | 2024-08-28 | 8,851 | $0.62 | $5.5K | 84,782 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award | 2024-06-28 | 2024-07-02 | 1,064 | $19.94 | $21.2K | 75,931 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2024-06-11 | 2024-06-13 | 2,825 | $22.64 | $64.0K | 74,867 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2024-03-13 | 2024-03-15 | 723 | $28.33 | $20.5K | 77,692 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2024-03-04 | 2024-03-06 | 10,646 | — | $0 | 74,354 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2024-03-04 | 2024-03-06 | 10,000 | — | $0 | 15,172 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2024-03-04 | 2024-03-06 | 10,646 | $21.09 | $224.5K | 99,061 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2024-03-04 | 2024-03-06 | 10,000 | $6.36 | $63.6K | 88,415 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2024-03-04 | 2024-03-06 | 20,646 | $35.49 | $732.7K | 78,415 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2023-12-14 | 2023-12-18 | 597 | $20.76 | $12.4K | 77,910 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award deriv | 2023-12-08 | 2023-12-12 | 146,237 | — | $0 | 146,237 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award | 2023-12-08 | 2023-12-12 | 32,497 | — | $0 | 78,507 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2023-09-21 | 2023-09-25 | 5,000 | — | $0 | 25,172 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2023-09-21 | 2023-09-25 | 2,800 | $47.85 | $134.0K | 48,210 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2023-09-21 | 2023-09-25 | 2,200 | $48.36 | $106.4K | 46,010 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2023-09-21 | 2023-09-25 | 5,000 | $6.36 | $31.8K | 51,010 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2023-09-13 | 2023-09-25 | 617 | $50.34 | $31.1K | 46,010 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2023-08-28 | 2023-08-30 | 5,745 | — | $0 | 30,172 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2023-08-28 | 2023-08-30 | 500 | $50.67 | $25.3K | 46,627 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2023-08-28 | 2023-08-30 | 5,245 | $49.92 | $261.8K | 47,127 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2023-08-28 | 2023-08-30 | 5,745 | $6.36 | $36.5K | 52,372 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2023-06-23 | 2023-06-23 | 500 | $51.41 | $25.7K | 46,627 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2023-06-23 | 2023-06-23 | 10,500 | $50.73 | $532.7K | 47,127 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2023-06-22 | 2023-06-23 | 11,000 | $52.18 | $574.0K | 57,627 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2023-06-21 | 2023-06-23 | 11,349 | $52.26 | $593.1K | 68,627 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2023-06-13 | 2023-06-15 | 591 | $55.16 | $32.6K | 79,976 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | F Tax w/h | 2023-03-10 | 2023-03-14 | 701 | $43.46 | $30.5K | 80,567 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2023-01-13 | 2023-01-18 | 1,534 | $49.89 | $76.5K | 83,686 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2023-01-13 | 2023-01-18 | 1,105 | $51.99 | $57.4K | 81,268 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2023-01-13 | 2023-01-18 | 1,313 | $51.18 | $67.2K | 82,373 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2023-01-13 | 2023-01-18 | 1,048 | $49.12 | $51.5K | 85,220 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award deriv | 2022-12-16 | 2022-12-20 | 29,073 | — | $0 | 87,221 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2022-12-12 | 2022-12-13 | 402 | $43.77 | $17.6K | 86,268 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2022-12-12 | 2022-12-13 | 4,598 | $43.18 | $198.5K | 86,670 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award deriv | 2022-12-09 | 2022-12-13 | 86,379 | — | $0 | 86,379 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award | 2022-12-09 | 2022-12-13 | 19,195 | — | $0 | 91,268 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2022-11-10 | 2022-11-14 | 100 | $39.96 | $4.0K | 72,073 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2022-11-10 | 2022-11-14 | 4,900 | $39.41 | $193.1K | 72,173 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2022-10-10 | 2022-10-12 | 5,000 | $37.99 | $189.9K | 77,073 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award deriv | 2022-09-13 | 2022-09-13 | 29,074 | — | $0 | 58,148 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2022-09-13 | 2022-09-15 | 26,014 | $27.18 | $707.1K | 96,059 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2022-09-13 | 2022-09-15 | 13,986 | $28.04 | $392.2K | 82,073 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award deriv | 2022-09-09 | 2022-09-13 | 29,074 | — | $0 | 29,074 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award | 2022-06-30 | 2022-09-13 | 1,152 | $8.03 | $9.3K | 122,073 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award deriv | 2021-12-08 | 2021-12-10 | 87,221 | — | $0 | 87,221 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2021-10-15 | 2021-10-18 | 12,400 | $21.58 | $267.6K | 121,021 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2021-10-15 | 2021-10-18 | 100 | $22.34 | $2.2K | 120,921 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2021-09-15 | 2021-09-17 | 10,500 | $24.57 | $258.0K | 135,421 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2021-09-15 | 2021-09-17 | 2,000 | $25.31 | $50.6K | 133,421 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2021-08-16 | 2021-08-17 | 10,000 | $18.79 | $187.9K | 145,921 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2021-07-15 | 2021-07-19 | 10,000 | $20.90 | $209.0K | 155,921 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award deriv | 2020-12-08 | 2020-12-09 | 77,580 | — | $0 | 77,580 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award | 2020-06-30 | 2020-12-09 | 1,245 | $17.07 | $21.3K | 164,914 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award | 2019-12-31 | 2020-01-03 | 1,025 | $18.87 | $19.3K | 163,669 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award deriv | 2019-12-13 | 2019-12-13 | 85,000 | — | $0 | 85,000 | SEC↗ |